TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Mark Drew
Business Programme Lead at AstraZeneca

Profile

  • Studied Chemistry at Oxford University
  • Joined AstraZeneca in 2006 as an Analytical Chemist
  • Worked on the development of small molecule products across development from first time in man to supporting on market products
  • Became a team manager in 2014 and led a team performing GMP testing across development products and subsequently led a team working on the development and commercial registration of a peptide product.
  • In my current role, I'm leading the implementation of a new chromatography data system and upgrade in separation science equipment across development as well as supporting implementation of new technologies to Operations QC sites.

Mark Drew's Network

Agenda Sessions

  • Understanding the 3-D structures of a Peptide to Determine the Control Strategy for Biological Activity

    , 09:25